Skip to main content
. Author manuscript; available in PMC: 2024 Apr 5.
Published in final edited form as: Phys Med Biol. 2023 Apr 5;68(8):10.1088/1361-6560/acc37c. doi: 10.1088/1361-6560/acc37c

Table 4.

Comparison of EQD2 dose metrics for automated plans compared to clinical plans. EQD2 incorporates the prior external beam radiotherapy dose and was computed assuming the dose for the single brachytherapy fraction was delivered for the entire course of treatment.

HRCTV D90 [Gy] Bladder D2cc [Gy] Rectum D2cc [Gy] Sigmoid D2cc [Gy]
Subject Auto Clinical Auto Clinical Auto Clinical Auto Clinical
1* 92.6 84.2** 59.1 56.7 71.7 63.6 77.4* 72.2
2* 97.7 85.5 96.7* 80.0 82.8* 73.4 75.9* 73.5
3* 98.2 96.6 95.9* 95.9* 80.8* 80.0* 73.9 72.7
4** 83.5** 84.4* 85.8 88.6 71.9 65.1 53.6 54.8
5 86.3 89.7 84.1 89.1 58.6 60.2 53.9 57.1
6* 99.2 96.3 60.6 59.2 68.0 65.5 78.0* 75.2*
7** 81.3** 79.8** 58.6 56.2 67.4 65.4 67.4 65.7
8** 81.5** 85.0 87.1 88.6 68.6 72.5 63.7 62.2
9* 111.0 90.5 79.6 72.4 55.3 54.9 77.1* 69.3
10 94.9 104.1 71.4 77.8 58.0 59.1 67.4 71.5
*

indicates the dose metric exceeded a hard maximum planning constraint (bladder D2cc > 90 Gy, rectum D2cc > 75 Gy, sigmoid D2cc > 75 Gy), while

**

indicates that the minimum HRCTV coverage D90 constraint (85 Gy) was not met.

Stars in the left column indicate whether the automated plan was generally too hot (*) or too cold (**).